Background: Alms1 mutant (foz/foz) mice develop hyperphagic obesity, diabetes, metabolic syndrome, and fatty liver (steatosis). High-fat (HF) feeding converts pathology from bland steatosis to nonalcoholic steatohepatitis (NASH) with fibrosis, which lead
This is an author's peer-reviewed final manuscript, as accepted by the publisher. The article is cop...
BACKGROUND: Metabolic disorders such as insulin resistance, obesity, and hyperglycemia are promin...
Introduction: In Norway, 58 % of men and 47 % of women are classified as overweight or obese, which ...
International audienceThe globally prevalent disease, non-alcoholic steatohepatitis (NASH), is chara...
Rationale: Innate immunity and insulin resistance constitute potential mechanisms underlying non-alc...
Non-alcoholic fatty liver disease (NAFLD) is a progressive disease associated with insulin resistanc...
The biochemical differences between simple steatosis, a benign liver disease, and non-alcoholic stea...
Fatty liver diseases are complications of the metabolic syndrome associated with obesity, insulin re...
Background & Aims: Obese Alms1 mutant (foz/foz) NOD.B10 mice develop diabetes and fibrotic NASH when...
Nonalcoholic fatty liver disease (NAFLD) encompasses a clinicopathologic spectrum of diseases rangin...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
Non-alcoholic fatty liver disease (NAFLD) is highly prevalent. 20-30% of patients with NAFLD progres...
Non-alcoholic fatty liver disease (NAFLD) is a liver disorder linked to obesity that is rapidly incr...
Fatty liver diseases are complications of the metabolic syndrome associated with obesity, insulin re...
AbstractThe major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin re...
This is an author's peer-reviewed final manuscript, as accepted by the publisher. The article is cop...
BACKGROUND: Metabolic disorders such as insulin resistance, obesity, and hyperglycemia are promin...
Introduction: In Norway, 58 % of men and 47 % of women are classified as overweight or obese, which ...
International audienceThe globally prevalent disease, non-alcoholic steatohepatitis (NASH), is chara...
Rationale: Innate immunity and insulin resistance constitute potential mechanisms underlying non-alc...
Non-alcoholic fatty liver disease (NAFLD) is a progressive disease associated with insulin resistanc...
The biochemical differences between simple steatosis, a benign liver disease, and non-alcoholic stea...
Fatty liver diseases are complications of the metabolic syndrome associated with obesity, insulin re...
Background & Aims: Obese Alms1 mutant (foz/foz) NOD.B10 mice develop diabetes and fibrotic NASH when...
Nonalcoholic fatty liver disease (NAFLD) encompasses a clinicopathologic spectrum of diseases rangin...
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance...
Non-alcoholic fatty liver disease (NAFLD) is highly prevalent. 20-30% of patients with NAFLD progres...
Non-alcoholic fatty liver disease (NAFLD) is a liver disorder linked to obesity that is rapidly incr...
Fatty liver diseases are complications of the metabolic syndrome associated with obesity, insulin re...
AbstractThe major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin re...
This is an author's peer-reviewed final manuscript, as accepted by the publisher. The article is cop...
BACKGROUND: Metabolic disorders such as insulin resistance, obesity, and hyperglycemia are promin...
Introduction: In Norway, 58 % of men and 47 % of women are classified as overweight or obese, which ...